Evidence of Different Profiles of Side Effects and Drug–Drug Interactions among the Quinolones _ The Pharmacokinetic Standpoint

作者: Hartmut Lode

DOI: 10.1159/000057841

关键词:

摘要: Recent pharmacokinetic data, interaction profiles, and specific tolerance problems associated with the fluoroquinolones are reviewed. Oral absorption was highest for levofloxacin (99–100%), 500 mg

参考文章(8)
G. Höffken, K. Borner, P. D. Glatzel, P. Koeppe, H. Lode, Reduced enteral absorption of ciprofloxacin in the presence of antacids. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 4, pp. 345- 345 ,(1985) , 10.1007/BF02013667
Karl-Matthias Deppermann, Hartmut Lode, Fluoroquinolones: Interaction Profile during Enteral Absorption Drugs. ,vol. 45, pp. 65- 72 ,(1993) , 10.2165/00003495-199300453-00013
Peter Ball, Lionell Mandell, Yoshihito Niki, Glenn Tillotson, Comparative tolerability of the newer fluoroquinolone antibacterials. Drug Safety. ,vol. 21, pp. 407- 421 ,(1999) , 10.2165/00002018-199921050-00005
Louise M. Dembry, Jane M. Farrington, Vincent T. Andriole, FLUOROQUINOLONE ANTIBIOTICS : ADVERSE EFFECTS AND SAFETY PROFILES Infectious Diseases in Clinical Practice. ,vol. 8, pp. 421- 428 ,(1999) , 10.1097/00019048-199912000-00008
Annette Lubasch, Ivonne Keller, Klaus Borner, Peter Koeppe, Hartmut Lode, Comparative Pharmacokinetics of Ciprofloxacin, Gatifloxacin, Grepafloxacin, Levofloxacin, Trovafloxacin, and Moxifloxacin after Single Oral Administration in Healthy Volunteers Antimicrobial Agents and Chemotherapy. ,vol. 44, pp. 2600- 2603 ,(2000) , 10.1128/AAC.44.10.2600-2603.2000
Van Der Linden, Van De Lei, Nab, Knol, Stricker, Achilles tendinitis associated with fluoroquinolones British Journal of Clinical Pharmacology. ,vol. 48, pp. 433- 437 ,(1999) , 10.1046/J.1365-2125.1999.00016.X
S C Chien, M C Rogge, L G Gisclon, C Curtin, F Wong, J Natarajan, R R Williams, C L Fowler, W K Cheung, A T Chow, Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 2256- 2260 ,(1997) , 10.1128/AAC.41.10.2256
RALF STAHLMANN, HARTMUT LODE, Safety Overview: Toxicity, Adverse Effects, and Drug Interactions The Quinolones. pp. 201- 233 ,(1988) , 10.1016/B978-0-12-059515-0.50010-X